We are live on ! Find out more
FTXH icon

First Trust Nasdaq Pharmaceuticals ETF

71 hedge funds and large institutions have $985M invested in First Trust Nasdaq Pharmaceuticals ETF in 2026 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

418,483% more capital inflows, than outflows

Capital inflows: $930M | Capital outflows: $222K

4,100% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 1

400% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 4

137% more funds holding

Funds holding: 30 → 71 (+41)

27.12% more ownership

Funds ownership: 65.08% → 92.2% (+27%)

Holders
71
Holders Change
+41
Holders Change %
+136.67%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
20
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

FTXH Hedge Fund Activity: Q3 2026 in Review

71 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q3 2026, worth a combined $985M — up 4,070% from $23.6M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new FTXH positions and 1 closed out — a net gain of 41 holders — while 20 added to existing stakes and 4 trimmed.

The largest buyer was First Trust Advisors, opening a new position worth an estimated $769M. The largest seller was International Assets Investment Management, exiting entirely with an estimated $168K sold.

  • 71 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q3 2026, up from 30 in Q2 2026.
  • Funds reported $985M of First Trust Nasdaq Pharmaceuticals ETF stock for Q3 2026, up 4,070% quarter-over-quarter.
  • 42 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q3 2026 and 1 closed out, a net change of +41 holders.
  • The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q3 2026 was First Trust Advisors, an estimated $769M added.
  • The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q3 2026 was International Assets Investment Management, an estimated $168K sold.

Based on aggregated 13F filings for Q3 2026.